Combination therapy with diuretics: An evolution of understanding

American Journal of Medicine

Volumn 101, Issue 3 A, 1996, Pages 61S-70S

  Neutel, Joel M ^a,d   Black, Henry R ^b   Weber, Michael A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^d ST JOSEPH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GUANETHIDINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; METHYLDOPA; METOPROLOL; RESERPINE; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CLINICAL PROTOCOL; DIURETIC THERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; BLOOD PRESSURE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; PATHOPHYSIOLOGY;

BLOOD PRESSURE; CLINICAL TRIALS; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0030606967     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00269-0     Document Type: Review

References (82)

1. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
2. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, et al. Treatment of mild hypertension study (TOMHS): final results. JAMA. 1993;270:713-724.
3. Johnson CI, Arnolda LF, Hiwatari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs. 1984;27:271.
4. Omvik P, Tarazi RC, Bravo EL. Regulation of sodium balance in hypertension. Hypertension. 1980;2:515.
5. Luft FC, Fineberg NS, Weinberger MH. Long-term effect of nifedipine and hydrochlorothiazide on blood pressure and sodium homeostasis at varying levels of salt intake in mildly hypertensive patients. Am J Hypertens. 1991;4:752-760.
6. Postma CT, Dennesen PJW, deBoo T, Thien T. First dose hypotension after captopril; can it be predicted? A study of 240 patients. J Hum Hypertens. 1992;6:205-209.
7. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a β-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990; 150:1707-1713.
8. Andren L, Weiner L, Svensson A, Hansson L. Enalapril with either a "very low" or "low" dose of hydrochlorothiazide is equally effective in essential hypertension: a double-blind trial in 100 hypertensive patients. J Hypertens. 1983;1(suppl 2):384-386.
9. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med. 1990;150:1175-1183.
10. Wyndham RN, Gimenez L, Walker WF, et al. Influence of renin levels on the treatment of essential hypertension with thiazide diuretics. Arch Intern Med. 1987;147:1021.
11. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low dose hydrochlorothiazide in patients with essential hypertension. Arch Intern Med. 1996;156:278-285.
12. Cruickshank JM. The case for beta blockers as first-line antihypertensive therapy. J Hypertens. 1992;10(suppl):S21-S27.
13. Buhler FR. The case for calcium antagonists as first-line treatment of hypertension. J Hypertens. 1992;10(suppl):S17-20.
14. Drayer JIM, Keim HJ, Weber MA, Case DB, Laragh JH. Unexpected pressor responses to propranolol in essential hypertension: an interaction between renin, aldosterone and sympathetic activity. Am J Med. 1976;60:897-903.
15. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med. 1994;154:1461-1468.
16. Opu LH. Calcium channel antagonists. Part III. Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. Cardiovasc Drugs Ther. 1988;1:625-656.
17. Kaplan NM. Calcium entry blockers in the treatment of hypertension: current status and future prospects. JAMA. 1989;262:817-823.
18. Valdes G, Soto ME, Croxatto HR, Bellolio T, Corbalan R, Casanegra P. Effects of nifedipine during low, normal and high intakes of sodium in patients with essential hypertension. Clin Sci. 1982;63:447S-450.
19. Magagna A, Abdel-Haq B, Pedrinelli R, Salvetti A. Does chlorthalidone increase the hypotensive effect of nifedipine? J Hypertens. 1986;4(suppl):S519-S521.
20. Nicholson JP, Resnick LM, Laragh JH. The antihypertensive effect of verapamil at extremes of dietary sodium intake. Ann Intern Med. 1987;107:329-334.
21. Garthoff B, Bellemann P. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats. J Cardiovasc Pharmacol. 1987;10(suppl 10):S36-S39.
22. Leenen FHH, Yuan B. Dietary sodium and the antihypertensive effect of nifedipine in spontaneously hypertensive rats. Am J Hypertens. 1992; 5:515-519.
23. Cappuccio FP, Markandu ND, Singer DRJ, et al. A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine. Am J Hypertens. 1991;4:297-302.
24. Salvetti A, Magagna A, Innocenti P, et al. The combination of chlorthalidone with nifedipine does not exert an additive antihypertensive effect in essential hypertensives: a crossover multicenter study. J Cardiovasc Pharmacol. 1991;17:332-335.
25. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. An assessment of diltiazem and hydrochlorothiazide in hypertension: application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA. 1990;263:1507-1512.
26. Di Somma S, Loguori V, Petitto M, Cavallotti G, Savonitto S, de Divitis O. Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients. Cardiovasc Drugs Ther. 1990;4:1151-1156.
27. Weir MR, Weber MA, Punzi HA, Serfer HM, Rosenblatt S, Cady WJ. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension. J Hum Hypertens. 1992;6:133-138.
28. Thulin T, Hedner T, Gustafsson S, Olsson S-O. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. J Hum Hypertens. 1991;5:107-114.
29. Elliott WJ, Polascik TB, Murphy MB. Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor. J Hum Hypertens. 1990;4:717-723.
30. Carruthers G, Dessain P, Fodor G, Newman C, Palmer W, Sim D. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. Am J Cardiol. 1993;71:575-581.
31. Batley DM, Nicolich MJ, Lasser VI, Jeffrey SS, Lasser NL. Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients. Am J Med. 1989;86:74-78.
32. Cheung DG, Hoffman CA, Ricci ST, Weber MA. Mild hypertension in the elderly: a comparison of prazosin and enalapril. Am J Med. 1989;86:87-90.
33. Finnerty FA, Davidov M, Mroczek WJ, Gavrilovich L. Influence of extracellular fluid volume on response to antihypertensive drugs. Circ Res. 1970;26(suppl 1):71-80.
34. Materson BJ, Reda DJ, Preston RA, et al. Response to a second single antihypertensive agent as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 1995;155:1757-1762.
35. Bauer JH, Gaddy P. Effects of enalapril alone, and in combination with hydrochlorothiazide, on renin-angiotensin-aldosterone, renal function, salt and water excretion, and body fluid composition. Am J Kidney Dis. 1985;6:222-232.
36. Franklin SS, Smith RD. A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension. Nephron. 1986;44:73-82.
37. Reams GP, Bauer JH. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition. J Clin Hypertens. 1986;2:55-63.
38. Jones DW, Sands CD. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide. Pharmacotherapy. 1991;11:127-130.
39. Mittman N, Dubrow A, Westerman M, Flamenbaum W. Combination therapy with enalapril and hydrochlorothiazide: optimal dose, renin response, and prostaglandin excretion. J Clin Hypertens. 1986;2:30-38.
40. Vidt DG. A controlled multiclinic study to compare the antihypertensive effects of MK-421, hydrochlorothiazide in patients with mild to moderate essential hypertension. J Hypertens. 1984;2:S81-S88.
41. Weir MR, Lavin PT, Byrnes CA. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor. Clin Ther. 1993;15:527-538.
42. Leonetti G, Cuspidi C, Sampieri L, et al. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study. J Hum Hypertens. 1990;4:5-11.
43. Stroh JA, Saltzberg S, Weinberg P, Shamoon H, Charlap S, Frishman W. Rest and exercise hemodynamic and adrenergic responses to enalapril, hydrochlorothiazide, and combination treatment in patients with systemic hypertension. J Clin Hypertens. 1985;1:35-48.
44. Strocchi E, Bossini A, Ranieri G, Filitti V. Efficacy and tolerability of enalapril (20 mg)/hydrochlorothiazide (12.5 mg) combination therapy in essential hypertension. Clin Ther. 1991;13:737-746.
45. Lore W, Muita AK, Ogola ESN. The efficacy and tolerability of enalapril-hydrochlorothiazide combination as a first line therapy in black patients with mild to moderate arterial hypertension: a clinical study in Kenya. East Afr Med J. 1992;69:18-21.
46. Middlemost SJ, Tager R, Davis J, Sareli P. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol. 1994;73:1092-1097.
47. Rosenthal T, Grossman E, Rathaus M, et al. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. Israel J Med Sci. 1990;26:63-66.
48. Guul SJ, Os I, Jounela AJ. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy. Am J Hypertens. 1995;8:727-731.
49. Graham RD. Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination. J Hum Hypertens. 1991;5:59-61.
50. Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. Intern Arch Med. 1994;154:737-743.
51. Lang H. The results of a large multicentre study comparing low-dose lisinopril-hydrochlorothiazide with the monocomponents. J Hum Hypertens. 1991;5:73-76.
52. Miller E. Introduction to lisinopril-hydrochlorothiazide combination. J Hum Hypertens. 1991;5:49-51.
53. Hart W. Lisinopril-hydrochlorothiazide combination compared with the monocomponents in elderly hypertensive patients. J Hum Hypertens. 1991;5:85-89.
54. Pathe M. Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension. J Hum Hypertens. 1991;5:53-54.
55. Pool JL. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991;122:926-931.
56. Canter D, Frank GJ, Knapp LE, et al. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. J Hum Hypertens. 1994;8:155-162.
57. Pandhi P, Mondal S, Sharma BK, Sharma PL, Wahi PL. Low-dose captopril alone and in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension. Inter J Clin Pharmacol Ther Toxicol. 1986;24:294-297.
58. Andrén L, Karlberg B, Ohman P, Svensson A, Asplund J, Hansson L. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol. 1982;14:107S-111S.
59. Costa FV, Borghi C, Mussi A, Ambrosioni E. Antihypertensive efficacy of two low dosages of hydrochlorothiazide in patients treated with captopril. Clin Ther. 1985;7:717-724.
60. Holzgreve H, Osterkorn K, Runge J. Captopril in combination with hydrochlorothiazide: comparative efficacy vs perceived best therapy. Br J Clin Pharm. 1987;23:93S-101S.
61. Lacourciere Y, Poirier L, Provencher P, Guivarc'h PH. Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination. Br J Clin Pharmacol. 1991;32:115-119.
62. Meijer JL, Ardesch HG, Van Rooijen JC, De Bruijn JHB. Captopril plus hydrochlorothiazide once daily normalizes 24 h blood pressure in patients with essential hypertension. Br J Clin Pharm. 1987;23:83S-88S.
63. Perani G, Martignoni A, Muggia C, et al. Metabolic effects of the combination of captopril and hydrochlorothiazide in hypertensive subjects. J Clin Pharmacol. 1990;30:1031-1035.
64. Poggi L, Vaisse B, Bernard F, Drivet-Perrin J, Sambuc R. Comparison of once and twice daily administration of captopril plus hydrochlorothiazide on 24 h blood pressure levels. Br J Clin Pharmacol. 1987;23:71S-75S.
65. Lacourciere Y, Gagne C. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension. J Hum Hypertens. 1993;7:149-152.
66. Lederle RM. Captopril and hydrochlorothiazide in the fixed combination multicenter trial. J Cardiovasc Pharmacol. 1985;7:S63-S69.
67. Woo J, Woo KS, Kin T, Vallance-Owen J. A single-blind, randomized, crossover study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly. Arch Intern Med. 1987;147:1386-1389.
68. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7:S52-S55.
69. Weinberger MH. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension. Br J Clin Pharmacol. 1982;14:127S-131S.
70. Creisson C, Baulac L, Lenfant B. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study. Postgrad Med J. 1986;62:139-141.
71. Steru D, Childs M, Lancrenon S, et al. Determination of the optimal dosage regimen of captopril + hydrochlorothiazide in the treatment of moderate arterial hypertension. Br J Clin Pharmacol. 1987;23:65S-69S.
72. Tuomilehto J, Nissinen A, Honkavaara M. Clinical evaluation of the antihypertensive effect of metoprolol in combination with hydrochlorothiazide and hydralazine in an unselected hypertensive population. Acta Cardiol. 1980;35:289-301.
73. Smilde JG. Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol. Eur J Clin Pharmacol. 1983;25:581-583.
74. Pollet A, Derde MP, Kaufman L. Evaluation of a fixed combination of metoprolol and hydrochlorothiazide in the treatment of elderly hypertensive patients. Acta Therapeutica. 1986;12:81-92.
75. Leikersfeldt G, Rasmussen SL, Atmer B, Hjalmers S, Wahlqvist I. Efficacy and tolerability of a fixed combination of metoprolol CR/ZOK 100 mg and hydrochlorothiazide (HCT) 12.5 mg in comparison with the fixed combination of metoprolol and HCT. J Clin Pharmacol. 1990;30:S78-S81.
76. Penman WA, Smith RG. Pilot study of antihypertensive treatment in the elderly. Practitioner. 1982;226:1180-1182.
77. Van Der Veur E, Ten Berge BS, Donker AJM, May JF, Schuurman FH, Wesseling H. A comparison between metoprol 200 mg and metoprolol 100 mg plus 12.5 mg hydrochlorothiazide in non-responders to an initial dose of metoprolol 100 mg in uncomplicated mild to moderate hypertension. Acta Therapeutica. 1987;13:25-38.
78. Groom P, Simpson RJ, Singh B, Ward DE, Peers E, Richardson PDI. A double-blind comparison of felodipine and hydrochlorothiazide added to metoprolol to control hypertension. Eur J Clin Pharmacol. 1988;34:21-24.
79. Holwerda K, Hoogma RPLM, Oldenbroek C, Huige RC, Wester A, Rijnierse JMM. Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy. Clin Ther. 1994;16:942-951.
80. Dahlöf B, Andren L, Eggersten R, Jern S, Svensson A, Hansson L. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide. J Hypertens. 1985;3: S483-S486.
81. Pool JL, Gennari J, Goldstein R, et al. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987;9:S36-S42.
82. Asplund J. A fixed-ratio combination of metoprolol and hydrochlorothiazide (Co-Betaloc) in essential hypertension: a comparison between the individual drugs. Curr Ther Res. 1981;29:387-394.